鄰近類別 圖書 [0/1] 會議論文/會議摘要 [22/23] 類別統計 近3年內發表的文件:21(19.81%) 含全文筆數:105(99.06%) 文件下載次數統計 下載大於0次:105(100.00%) 下載大於100次:105(100.00%) 檔案下載總次數:43118(80.26%) 最後更新時間: 2024-11-28 22:44 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Association of bone turnover marker... Plasma leptin levels are lower in f... Metabolic activity of CYP2C19 and C... Ketamine-dependent patients with pe... Metabolic activity of CYP2C19 and C... Psychometric evaluation of the Chin... Multi-ancestry genome-wide associat... Classifying Alzheimer's disease and... Meta-analysis of CYP2C19 and CYP2D6... The cysteine-altering p.R544C varia...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目76-100 / 106. (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2014-04	The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance	Journal of Clinical Psychopharmacology. 2014 Apr;34(2):205-211.
2013-12	Genetics and pharmacogenetics of substance use disorders	Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S23-S24.
2013-12	Pharmacogenomics study in a Taiwanese methadone maintenance cohort	Journal of Food and Drug Analysis. 2013 Dec;21(4 Suppl.):S62-S68.
2013-11	Comparison of escitalopram and paroxetine in the treatment of major depressive disorder	International Clinical Psychopharmacology. 2013 Nov;28(6):339-345.
2013-09	Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort	OMICS :A Journal of Integrative Biology. 2013 Sep;17(10):519-526.
2013-07-23	Hepatitis C Virus infection influences the S-methadone metabolite plasma concentration	PLoS ONE. 2013 Jul 23;8(7):Article number e69310.
2013-07	CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions	Pharmacogenomics. 2013 Jul;14(10):1191-1201.
2013-03-28	The DAO gene is associated with schizophrenia and interacts with other genes in the Taiwan Han Chinese population	PLoS ONE. 2013 Mar 28;8(3):Article number e60099.
2013-02	OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: A cross sectional study	Journal of Human Genetics. 2013 Feb;58(2):84-90.
2013-02	PXR polymorphisms interacted with CYP2B6 polymorphisms on methadone metabolites	Journal of Clinical Psychopharmacology. 2013 Feb;33(1):137-140.
2012-10	Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients	European Neuropsychopharmacology. 2012 Oct;22(10):695-703.
2012-06	UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients	Pharmacogenomics. 2012 Jun;13(8):879-888.
2012-03	Genome-wide association study of treatment refractory schizophrenia in Han Chinese	PLoS ONE. 2012 Mar;7(3):Article number e33598.
2011-12	Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia	Journal of Clinical Psychopharmacology. 2011 Dec;31(6):758-762.
2011-10	Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients	Pharmacogenomics. 2011 Oct;12(10):1397-1406.
2011-08	CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer	Journal of Clinical Psychopharmacology. 2011 Aug;31(4):463-469.
2011-06	ANXA7, PPP3CB, DNAJC9, and ZMYND17 Genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function	Biological Psychiatry. 2011 Jul;70(1):51-58.
2011-04	ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment	Pharmacogenetics and Genomics. 2011 Apr;21(4):163-170.
2010-11	CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine	Pharmacogenomics. 2010 Nov;11(11):1535-1543.
2010-07	Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients	Biomedical Chromatography. 2010 Jul;24(7):782-788.
2010-04	Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response	Pharmacogenomics. 2010 Apr;11(4):537-546.
2010-01-14	Genetic variants of IL-6 and its receptor are not associated with schizophrenia in Taiwan	Neuroscience Letters. 2010 Jan 14;468(3):330-333.
2009-11	Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p	Genes, Brain and Behavior. 2009 Nov;8(8):785-794.
2009-07	Construction of Balanced Translocation t(1;11)(q42.1;q14.3) Probe and Screening Application in Genomic Samples in Taiwan	Journal of the Formosan Medical Association. 2009 Jul;108(7):587-591.
2009-04	Association of the 3'region of COMT with Schizophrenia in Taiwan	Journal of the Formosan Medical Association. 2009 Apr;108(4):301-309.

顯示項目76-100 / 106. (共5頁) << < 1 2 3 4 5 > >> 每頁顯示[10|25|50]項目